首頁 > 市場調查報告書 > 製藥

糖尿病

市場調查報告書

商品編碼

1672637

糖尿病視網膜病變市場：依疾病類型、治療類型、給藥途徑、最終用途、通路及地區分類

Diabetic Retinopathy Market, By Disease Type, By Treatment Type, By Route of Administration, By End User, By Distribution Channel, By Geography

出版日期: 2025年02月07日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球糖尿病視網膜病變市場規模估計為 99.1 億美元，預計到 2032 年將達到 154 億美元，2025 年至 2032 年的複合年成長率為 6.5%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	99.1億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	6.50％	2032 年價值預測	154億美元

數字。 2025 年糖尿病視網膜病變市場佔有率（按地區分類）

糖尿病視網膜病變是糖尿病併發症，會導致視網膜受損。糖尿病引起的高血糖值會損害視網膜內的血管。糖尿病視網膜病變發生在第 1 型和第 2 型糖尿病中，是工作年齡族群失明的主要原因。全球糖尿病視網膜病變市場的發展受到糖尿病盛行率上升、對糖尿病視網膜病變診斷和治療認知的提高以及先進視網膜篩檢技術的普及等因素的推動。然而，高昂的治療費用和不佳的報銷政策限制了市場的成長。

市場動態：

視網膜篩檢、藥物和手術的高成本、新興國家眼科醫生的短缺以及一些國家保險覆蓋不足預計將抑制市場的成長。關鍵機會在於開發具有成本效益的篩檢解決方案、聯合療法和人工智慧分析平台，以便更快、更準確地檢測糖尿病視網膜病變。

本研究的主要特點

本報告對全球糖尿病視網膜病變市場進行了詳細分析，並提供了預測期（2025-2032，以 2024 年為基準年）的市場規模和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球糖尿病視網膜病變市場的主要企業概況。

這項研究涉及的主要企業包括諾華公司、拜耳公司、再生元製藥公司、羅氏控股公司、艾爾建公司、蔡司國際、托普康公司、海德堡工程有限公司、Optos PLC、佳能公司、尼德克有限公司、Ellex Medical Lasers Limited、博士倫公司、雅培實驗室和參天製藥株式會社。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球糖尿病視網膜病變市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 9.91 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 15.40 Bn

Diabetic retinopathy is a medical condition in which damage occurs to the retina due to complications of diabetes mellitus. High blood sugar levels associated with diabetes can damage blood vessels inside the retina. Diabetic retinopathy occurs in both type 1 and type 2 diabetes and is a leading cause of blindness among working-age adults. The global diabetic retinopathy market is driven by rising prevalence of diabetes, increasing awareness regarding diabetic retinopathy diagnosis and treatment, and the availability of advanced retinal screening techniques. However, high cost of treatment and inadequate reimbursement policies limit the market growth.

Market Dynamics:

High cost of retinal screening, drugs, and surgeries, shortage of ophthalmologists in developing nations, and inadequate insurance coverage in some countries are expected to restrain the market growth. Key opportunity lies in development of cost-effective screening solutions, combinational therapeutics, and artificial intelligence-powered analytic platforms to detect diabetic retinopathy faster and more accurately.

Key Features of the Study:

This report provides in-depth analysis of the global diabetic retinopathy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global diabetic retinopathy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Novartis AG, Bayer AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Allergan PLC, Zeiss International, Topcon Corporation, Heidelberg Engineering GmbH, Optos PLC, Canon Inc., Nidek Co., Ltd., Ellex Medical Lasers Limited, Bausch + Lomb Incorporated, Abbott Laboratories, and Santen Pharmaceutical Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global diabetic retinopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

By Disease Type Insights (Revenue, USD Bn, 2019 - 2032)
- Proliferative Diabetic Retinopathy
- Non-proliferative Diabetic Retinopathy
By Treatment Type Insights (Revenue, USD Bn, 2019 - 2032)
- Anti-Vascular Endothelial Growth Factor Therapy
- Intraocular Steroid Injection
- Laser Surgery
- Vitrectomy
- Others (Intraocular Corticosteroids, etc.)
By Route of Administration Insights (Revenue, USD Bn, 2019 - 2032)
- Intravitreal Injections
- Intravitreal Implants
- Oral
- Topical Eye Drops
- Laser Surgery
- Others
By End User Insights (Revenue, USD Bn, 2019 - 2032)
- Hospitals
- Ophthalmology Clinics
- Ambulatory Surgery Centers
- Long-Term Care Centers
- Others
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2019 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- Bayer AG
- Regeneron Pharmaceuticals Inc.
- Roche Holding AG
- Allergan PLC
- Zeiss International
- Topcon Corporation
- Heidelberg Engineering GmbH
- Optos PLC
- Canon Inc.
- Nidek Co., Ltd.
- Ellex Medical Lasers Limited
- Bausch + Lomb Incorporated
- Abbott Laboratories
- Santen Pharmaceutical Co., Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Diabetic Retinopathy Market, By Disease Type
- Global Diabetic Retinopathy Market, By Treatment Type
- Global Diabetic Retinopathy Market, By Route of Administration
- Global Diabetic Retinopathy Market, By End User
- Global Diabetic Retinopathy Market, By Distribution Channel
- Global Diabetic Retinopathy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Diabetic Retinopathy Market, By Disease Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Proliferative Diabetic Retinopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Non-proliferative Diabetic Retinopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Diabetic Retinopathy Market, By Treatment Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Anti-Vascular Endothelial Growth Factor Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intraocular Steroid Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laser Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Vitrectomy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Intraocular Corticosteroids, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Diabetic Retinopathy Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravitreal Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intravitreal Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Topical Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laser Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Diabetic Retinopathy Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ophthalmology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Long-Term Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Diabetic Retinopathy Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Diabetic Retinopathy Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
Regeneron Pharmaceuticals Inc.
Roche Holding AG
Allergan PLC
Zeiss International
Topcon Corporation
Heidelberg Engineering GmbH
Optos PLC
Canon Inc.
Nidek Co., Ltd.
Ellex Medical Lasers Limited
Bausch + Lomb Incorporated
Abbott Laboratories
Santen Pharmaceutical Co., Ltd.